You are here:
Publication details
Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.
Authors | |
---|---|
Year of publication | 2011 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |